Sandoz settles US antitrust case for $275m

Sandoz (SIX:SDZ), a division of Novartis (SIX:NOVN), has reached a $275 million settlement agreement with the end payer plaintiffs in a US...
17 hours ago
from: Investing.com

Competition law, Generic drug, Sandoz, Settlement

More about this

- Sandoz chalks up another settlement in US generic drug price fixing case
Sandoz will pay $275 million to settle further claims under the US generic drug industry antitrust litigation, ticking another group of...
from: FirstWord Pharma

- Sandoz moves to resolve legacy US generic drug antitrust class action litigation
Swiss generic and biosimilar medicines major Sandoz today announced a number of steps to resolve the US Generic Drug Antitrust Class Action...
from: The Pharma Letter

- Swiss drugmaker Sandoz settles US anti-trust charges
The Swiss generic drugs manufacturer Sandoz has agreed to pay more than $500 million to settle legacy United States anti-trust legal issues.
from: SWI swissinfo.ch

- Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation
Sandoz has agreed to pay another group of plaintiffs in the long-running price-fixing litigation it inherited from former parent company...
from: FiercePharma

- Sandoz Agrees 275 Mn Settlement Of US Class Action
Swiss generic medicines firm Sandoz on Tuesday said it had reached a $275 million settlement with plaintiffs in a legacy US generic drug...
from: Barron's

- Sandoz Enters $275 Million Settlement Deal in U.S. Case
A box of Prednisolone by Sandoz. The company entered into a settlement agreement for $275 million as part of a legacy U.S. generic drug...
from: MSN

- Sandoz: measures to resolve US antitrust dispute
Sandoz today announced a series of steps aimed at resolving the U.S. generic antitrust class action litigation. Sandoz has reached a...
from: marketscreener.com

- Sandoz Cuts $275M Deal For More Price-Fixing Claims
Swiss drugmaker Sandoz said Tuesday it has reached a $275 million settlement to end claims from consumers, insurers and others in the...
from: Law360

- Sandoz inks $275M settlement in generic antitrust litigation
Sandoz has agreed to pay $275 million to settle multidistrict generic price-fixing claims brought by a group that includes some insurers and...
from: Endpoints News